.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A randomized controlled study evaluated pulmonary rehabilitation after hospitalization for an acute COPD exacerbation. Patients were assigned to a structured rehabilitation program beginning soon after discharge or to usual care, with outcomes including exercise performance and health-related quality of life. Early rehabilitation produced meaningful improvements in walking capacity and patient-reported health status compared with usual care. These findings reinforce the idea that the period after an exacerbation is not only a time of relapse risk but also a window for functional recovery and secondary prevention. The NAPCON workshop on pulmonary rehabilitation and the rehabilitation/palliative symposium both emphasize structured, patient-centered programs, and this evidence provides a practical foundation for that approach. For HCPs, pulmonary rehabilitation should be considered an active treatment strategy rather than an optional add-on, especially for patients with persistent exercise limitation or recurrent admissions. At the same time, timing and patient stability matter: “early” does not mean indiscriminately starting intensive exercise before the patient is clinically ready. The paper supports integrating exercise training, education and follow-up into post-exacerbation pathways.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A randomized controlled study evaluated pulmonary rehabilitation after hospitalization for an acute COPD exacerbation. Patients were assigned to a structured rehabilitation program beginning soon after discharge or to usual care, with outcomes including exercise performance and health-related quality of life. Early rehabilitation produced meaningful improvements in walking capacity and patient-reported health status compared with usual care. These findings reinforce the idea that the period after an exacerbation is not only a time of relapse risk but also a window for functional recovery and secondary prevention. The NAPCON workshop on pulmonary rehabilitation and the rehabilitation/palliative symposium both emphasize structured, patient-centered programs, and this evidence provides a practical foundation for that approach. For HCPs, pulmonary rehabilitation should be considered an active treatment strategy rather than an optional add-on, especially for patients with persistent exercise limitation or recurrent admissions. At the same time, timing and patient stability matter: “early” does not mean indiscriminately starting intensive exercise before the patient is clinically ready. The paper supports integrating exercise training, education and follow-up into post-exacerbation pathways.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
